论文部分内容阅读
为了探讨乙型肝炎的免疫疗法,我们观察了小牛胸腺素对乙肝病人血清中花结抑制因子(RIF)的影响。结果表明:胸腺素不仅能在体内、外降低或消除RIF活性,而且注射胸腺素后能使慢性活动性肝炎病人的肝功能和临床症状得以改善。
To investigate the immunotherapy of hepatitis B, we examined the effect of calf thymosin on the level of floral-knot inhibitor (RIF) in hepatitis B patients. The results showed that thymosin can not only reduce or eliminate RIF activity in vitro and in vivo, but also improve the liver function and clinical symptoms of patients with chronic active hepatitis after injection of thymosin.